Pharmacy

CVS bolsters healthcare image

The national drugstore chain says it's getting out of the tobacco business.

Business briefs: GSK and Sanofi, plus state legislative news

GlaxoSmithKline says it is scaling back on acquisitions; Sanofi's CEO picks a regulatory fight; Maine wants to allow Ex-US meds; and New York State seeks to empower pharmacists.

Business briefs: Pfizer and CVS; the EMA; Digitas Health New York

Pfizer's online Viagra deal with CVS; reorg at the EMA; Mills moves up at Digitas

Remedy offers docs (and advertisers) a platform for direct communication with patients

By

Remedy Health is looking to close the loop—and sell advertising off of it—with the launch of a service letting doctors, pharmacies and other healthcare providers send topical health content to their patients.

Op/Ed: Meningitis crisis and the threat to pharma

Op/Ed: Meningitis crisis and the threat to pharma

By

The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.

Company news: FDA, Ranbaxy, Daiichi Sankyo and ImpactRx

The FDA issued Driving Innovation, a blueprint for fostering American biomedical innovation, reiterating a prior commitment to reform regulation and announcing policies aimed at facilitating personalized medicine.

Company news: K-V Pharmaceutical and Ther-Rx

In a blow to K-V Pharmaceutical, the FDA said it will not take action against pharmacies that make hydroxyprogesterone caproate, the active ingredient in K-V's recently approved pre-term labor prevention drug Makena.

Walgreens partners with Epocrates to highlight drug rebates

Walgreens partners with Epocrates to highlight drug rebates

By

Walgreens is hoping physicians will consider its "Prescription Savings Club" list of over 8,000 brand and generic drugs before deciding which script to write for underinsured or cash-strapped patients. Epocrates will provide point of care access to the list via mobile device starting today.

Novartis exploits J&J recall pains with Triaminic giveaway

Novartis exploits J&J recall pains with Triaminic giveaway

By

Novartis is capitalizing on rival J&J's woes with a giveaway of its new Triaminic OTC children's acetaminophen.

Scripts going unfilled at 'unprecedented' rate

By

Patients not taking or refilling medications on time costs the pharmaceutical industry billions each year. The housing bubble and recession have helped write a new chapter in the compliance story, as higher numbers of new prescriptions simply go unfilled because patients either cannot afford, or are unwilling, to pay for them.

Pharmacy adherence pilot boosted refills 36%

By

Pharmacies that counseled patients for a chronic COPD/respiratory drug saw an average increase in refill rates of more than 36% through the fifth fill, said McKesson.

Cardinal Health launches in-pharmacy ad network

By

Cardinal Health launched the Pharmacy Health Network in early August, serving up digital prescription and OTC advertising in 3,000 independent retail and franchised pharmacies nationwide.

Rite Aid launches video site for OTC coupons

By

Schering-Plough, Novartis, J&J, Wyeth and others are using Rite Aid's new "video values" site to offer coupons and information about their products.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.